+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infectious Disease Drug"

From
From
Infectious Disease Therapeutics Market Report 2025 - Product Thumbnail Image

Infectious Disease Therapeutics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Ebola Virus - Competitive Landscape, 2024 - Product Thumbnail Image

Ebola Virus - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
From
From
Global Markets for Infectious Disease Treatments - Product Thumbnail Image

Global Markets for Infectious Disease Treatments

  • Report
  • December 2021
  • 245 Pages
  • Global
From
From
Urinary Tract Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Loading Indicator

The Infectious Disease Drug market is a subset of the pharmaceutical industry that focuses on the development and production of drugs to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from bacterial and viral infections to fungal and parasitic diseases. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. They also work to ensure that their drugs are safe and effective. Some of the major players in the Infectious Disease Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Johnson & Johnson, and AstraZeneca. These companies are involved in the research, development, and production of drugs to treat a variety of infectious diseases. Show Less Read more